DAO and chronic kidney disease: Both markers were not elevated in our cohort of ESRD patients, in contrast to our previous findings, where we found elevated DAO, lipopolysaccharide binding protein and sCD14 levels in chronic kidney disease stage G3-5 patients, HD and PD patients and patients after kidney transplantation20.